tirzepatide and hypoglycemia Tirzepatide: A Promising Drug for Type 2 Diabetes Beyond Metabolic therapy is evolving faster

Seek urgent medical advice if you experience: Severe or persistent gastrointestinal symptoms: Whilst mild nausea is common with Wegovy, severe or persistent vomiting, severe abdominal pain (especially if radiating to the back), or signs of dehydration require immediate assessment, as these may indicate pancreatitis or other serious complications

With the right guidance and consistency, small steps can lead to big, lasting change." Wesley McWhorter, DrPH, Academy of Nutrition and Dietetics Navigating these challenges is easier with a personalized approach

This move marks a major development in the weight-loss drug market, which has been dominated by Novo Nordisk GLP-1 portfolio (Saxenda, Wegovy, Ozempic)

Hydration and electrolytes Maintaining fluid and electrolyte intake is commonly mentioned

Whether this carries over in to use in type 1 isnt clear